N-Cyclopropyl-4-nitro-2-(trifluoroMethyl)aniline
- $45 - $564
- Product name: N-Cyclopropyl-4-nitro-2-(trifluoroMethyl)aniline
- CAS: 1179935-12-6
- MF: C10H9F3N2O2
- MW: 246.19
- EINECS:
- MDL Number:
- Synonyms:N-Cyclopropyl-4-nitro-2-(trifluoroMethyl)aniline;Benzenamine, N-cyclopropyl-4-nitro-2-(trifluoromethyl)-
5 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 100mg
- 1g
- 5g
- 10g
- ManufacturerAK Scientific
- Product numberZ7877
- Product descriptionN-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline
- Packaging5g
- Price$531
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12175933
- Product descriptionN-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline 95+%
- Packaging5g
- Price$339
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12175933
- Product descriptionN-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline 95+%
- Packaging10g
- Price$564
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC986835
- Product descriptionN-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline
- Packaging100mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC986835
- Product descriptionN-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline
- Packaging1g
- Price$165
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | Z7877 | N-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline | 5g | $531 | 2021-12-16 | Buy |
Crysdot | CD12175933 | N-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline 95+% | 5g | $339 | 2021-12-16 | Buy |
Crysdot | CD12175933 | N-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline 95+% | 10g | $564 | 2021-12-16 | Buy |
TRC | C986835 | N-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline | 100mg | $45 | 2021-12-16 | Buy |
TRC | C986835 | N-Cyclopropyl-4-nitro-2-(trifluoromethyl)aniline | 1g | $165 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|